PharmacovigilanceOfficial

MHRA develops AdvanceGxP service to bring GxP advice into early innovation

🇬🇧 MHRA · Wed 18 Nov 2026

The UK regulator is building a free, regulator-led service to help developers of novel medicines technologies consider Good Practice requirements before key decisions are fixed; it is not yet open for applications.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced AdvanceGxP, a service in development that aims to help organisations working on novel medicines technologies consider Good Practice (GxP) requirements earlier. The agency says the goal is to reduce regulatory uncertainty while keeping regulatory and inspection decision-making independent.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.